BioMotiv, two universities launch Optikira

Drug development accelerator BioMotiv LLC (Cleveland, Ohio), the University of California San Francisco, and the University of Washington launched newco Optikira LLC

Read the full 220 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE